This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Conclusions Derived from Differences in Effect of Sodium /-Thyroxine, Sodium d-Thyroxine, Triiodothyronine, and Potassium Iodide on Uptake of Radioactive Iodine by Thyroid Gland of Normal Human Subjects

PAUL STARR, M.D.; RUTH LIEBHOLD-SCHUECK

AMA Arch Intern Med. 1953;92(6):880-888.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

STUDIES of synthetic sodium /-thyroxine demonstrate that as an oral medication in dosage of 0.5 mg. or less daily it is calorigenic and clinically active.¹ In similar dosage it has been shown to reduce the uptake of radioactive iodine.² Triiodothyronine, recently identified, synthesized, and demonstrated in human serum,³ also has been shown to be clinically effective⁴ and to be several times as potent as thyroxine.⁵

Curiosity as to the possible effect of sodium d-thyroxine led us to carry out tests with this substance. It was difficult to obtain. Dr. Leonard Ginger, of the Baxter Laboratories, Inc., Morton Grove, Ill., the source of the levo form used in our clinical studies, produced it for us. It has already been demonstrated by Greer⁶ that inorganic iodine in amounts equal to that in these medications has no effect upon uptake of radioactive iodine. We have, however, carried out a few tests at four-dose . . . [Full Text PDF of this Article]

Author Affiliations
LOS ANGELES

From the University of Southern California, School of Medicine, Department of Medicine, and the Los Angeles County General Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?